CHRONIC KIDNEY DISEASE MANAGEMENT IN PRIMARY CARE HANDBOOK REFRESHED FOR HCPs
Breonny Robson, GM Clinical and Research
Kidney Health Australia
Dr Chris Bollen GP, Oakden Medical Centre &
PEAK Committee Member, Kidney Health Australia
Professor Shilpa Jesudason, Nephrologist
Professor of Medicine, University of Adelaide,
Director of Dialysis, Royal Adelaide Hospital &
PEAK Committee Member, Kidney Health Australia
Chris Picton MP, Minister for Health and Wellbeing
Government of South Australia
Kidney Health Australia’s latest kidney disease guide for primary care practitioners is expected to be pivotal in slowing down the rates of kidney failure, which have doubled in the past 20 years and if left unchecked will grow by a further 42% by 2030, according to the health charity.
With specific reference to new kidney treatments and culturally safe kidney care for First Nations Australians, the 5th edition of Chronic Kidney Disease (CKD) Management in Primary Care handbook, known as the ‘kidney bible’, is a significant step-up in enabling earlier diagnosis of kidney disease for GPs and other front-line healthcare professionals.
The number of Australians treated for kidney failure has doubled in the last two decades, causing widespread treatment shortages, increasing costs, and plunging thousands of Australians into highly invasive and life-altering dialysis. With 1.8 million people currently unaware they have kidney disease, this number will only continue to grow.
Breonny Robson, General Manager, Clinical and Research at Kidney Health Australia, said: “The new edition of the GP handbook helps health professionals working in primary care to identify people at risk of CKD in their practice and proactively diagnose CKD. It outlines key strategies to slow the progression of CKD and reduce cardiovascular risk, including simple colour-coded action plans for different stages of the disease.”
Ms Robson added, “It’s an exciting time in CKD care, with new treatments now available that have been shown to slow the progression of CKD to kidney failure by 15 years or more. The handbook contains significant new information on using these medications in people with CKD so that their health outcomes and quality of life can be extended for many years to come.”
The handbook is endorsed by Australian and New Zealand Society of Nephrology (ANZSN), the Renal Society of Australasia (RSA) and the Australian Primary Healthcare Nurses Association (APNA) and Australian College of Rural and Remote Medicine (ACRRM). It has been approved as an Acceptable Clinical Resource by the Royal Australian College of General Practitioners (RACGP).
South Australian Minister of Health and Wellbeing Chris Picton launched the handbook at an event on World Kidney Day, 14th March, at Royal Adelaide Hospital.
The handbook is available from Kidney Health Australia in hardcopy or free download here https://kidney.org.au/health-professionals/ckd-management-handbook
-
Entering The New Health Frontier
A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant reforms to the health care system to ensure Australians have better and faster access to the wave of new medicines and technologies.
The bipartisan report makes 31 recommendations to reform Australia’s system for the regulation and reimbursement with the hope that patients will receive faster access to the latest medicines and technologies.
-
Surgical Site Infection (SSI) Synopsis, including modifiable and non-modifiable risk factors
Talking to the Australian Health Journal, Professor Russo states there is a particular concern in joint operations, such as hip or knee replacements, as infections in these areas can have severe consequences, including the removal of the infected joint, prolonged treatment, and significant costs for both hospitals and patients. Despite the substantial impact of surgical site infections, Australia lacks a national surveillance program for these infections, making it challenging to obtain accurate data. However, an estimate suggests that around 45,000 surgical site infections occur annually in Australia, resulting in approximately 900 deaths.
-
Sovereign capability uplifted
Skilled labour, in particular skilled in the manufacture of MTP products, namely competency in Good Manufacturing Practice (GMP), was identified as one of the key priorities, according to Jarrod Belcher, Director of the REDI Program at MTPConnect. Through a competitive process, MTPConnect selected additional industry training providers to deliver new programs addressing key skills gaps in the sector workforce.
Launched in September 2022, one of these programs is GMP Uplift developed by the Centre for Biopharmaceutical Excellence (CBE). CBE bring experience across large and small Biologics, Pharmaceuticals and Regenerative Medicine companies, both in consulting and GMP related enterprise training. CBE staff also have extensive experience in GMP operations, compliance, auditing and QMS design, a wide industry network for guest lecturers and readily available case studies.
